misonneh's moa [47 articles] Export

Recent papers added to misonneh's library classified by the tag moa. You can also see everyone's moa.

	The hallmarks of cancer. [My Copy] Cell, Vol. 100, No. 1. (7 January 2000), pp. 57-70. by D. Hanahan, R. A. Weinberg posted to review moa key cancer by misonneh on 2009-11-24 07:32:24 as along with 25 people bertelsen myzhang chemnerd1 ipark-kaist singhsh JeremyZucker Zephyrus rklancer guhjy kentsis Borelli jfr laurabailey archroad iskanbasal mhucka holmesjo SeungjoonOh cerami tibbitts waghsk zebkhan frohike catcremona gwenknight
	Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. [My Copy] Carcinogenesis, Vol. 29, No. 7. (July 2008), pp. 1459-1465. by Benjamin A. Rodriguez, Alfred S. Cheng, Pearlly S. Yan, et al.Dustin Potter, Francisco J. Agosto-Perez, Charles L. Shapiro, Tim H-M H. Huang posted to tamoxifen polycomb phenotype moa estrogen epigenetics breast by misonneh on 2009-11-24 06:51:57 as
	Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. [My Copy] Science (New York, N.Y.), Vol. 322, No. 5908. (12 December 2008), pp. 1695-1699. by Sooryanarayana Varambally, Qi Cao, Ram-Shankar S. Mani, et al.Sunita Shankar, Xiaosong Wang, Bushra Ateeq, Bharathi Laxman, Xuhong Cao, Xiaojun Jing, Kalpana Ramnarayanan, J. Chad Brenner, Jindan Yu, Jung H. Kim, Bo Han, Patrick Tan, Chandan Kumar-Sinha, Robert J. Lonigro, Nallasivam Palanisamy, Christopher A. Maher, Arul M. Chinnaiyan posted to moa mirna epigenetics by misonneh on 2009-11-24 06:44:55 as along with 7 people and 1 group fenghezi jfr winterschlaefer xingxu valeriehilgers NikkiD inesdesantiago microRNA
	Polycomb group proteins: navigators of lineage pathways led astray in cancer [My Copy] Nature Reviews Cancer, Vol. 9, No. 11. (01 November 2009), pp. 773-784. by Adrian P. Bracken, Kristian Helin posted to review pathway moa epigenetics by misonneh on 2009-11-19 05:56:08 as
	Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis [My Copy] The EMBO Journal, Vol. 28, No. 18. (20 August 2009), pp. 2719-2732. by Hong-li Yan, Geng Xue, Qian Mei, et al.Yu-zhao Wang, Fei-xiang Ding, Mo-Fang Liu, Ming-Hua Lu, Ying Tang, Hong-yu Yu, Shu-han Sun posted to p53 moa mirna apoptosis by misonneh on 2009-11-18 03:16:06 as along with 1 person valeriehilgers
	Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. [My Copy] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 16, No. 9. (1 September 2007), pp. 1700-1712. by Rebecca Troisi, Nancy Potischman, Robert N. Hoover posted to review moa intrauterine epidemiology breast by misonneh on 2009-11-15 16:07:46 as along with 1 person and 2 groups Zephyrus R.E.A.D Breast Cancer Reading Club
	MicroRNA involvement in the pathogenesis and management of breast cancer [My Copy] J Clin Pathol, Vol. 62, No. 5. (1 May 2009), pp. 422-428. by S. M. Khoshnaw, A. R. Green, D. G. Powe, I. O. Ellis posted to review pathology moa mirna breast by misonneh on 2009-11-10 05:49:29 as along with 2 people and 1 group tonamswish songpku microRNA
	The "hitchhiking effect" revisited. [My Copy] Genetics, Vol. 123, No. 4. (1 December 1989), pp. 887-899. by N. L. Kaplan, R. R. Hudson, C. H. Langley posted to statistics moa linkage hitchhiking haplotype genetics by misonneh on 2009-10-14 07:04:25 as along with 2 people renewang djkt
	Causes and consequences of microRNA dysregulation in cancer [My Copy] Nature Reviews Genetics, Vol. 10, No. 10. (01 October 2009), pp. 704-714. by Carlo M. Croce posted to review moa mirna cancer by misonneh on 2009-09-19 07:44:57 as along with 9 people and 1 group heliopais pattersonee frohike tonamswish valeriehilgers chrisamiller giovenko megraw ealloza microRNA
	Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells. [My Copy] Advances in experimental medicine and biology, Vol. 630 (2008), pp. 19-34. by Richard J. Santen, Robert X. Song, Shigeru Masamura, et al.Wei Yue, Ping Fan, Tetsuya Sogon, Shin-ichi Hayashi, Kei Nakachi, Hidtek Eguchi posted to tamoxifen review resistance moa estrogen breast by misonneh on 2009-09-08 07:14:52 as
	Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family [My Copy] Nat Rev Cancer, Vol. 9, No. 9. (September 2009), pp. 615-630. by Jianming Xu, Ray-Chang Wu, Bert W. O'Malley posted to steroid src review moa her2 breast by misonneh on 2009-08-26 11:38:59 as along with 2 people ondrej thegoose
	Biological determinants of endocrine resistance in breast cancer [My Copy] Nat Rev Cancer, Vol. 9, No. 9. (September 2009), pp. 631-643. by Elizabeth A. Musgrove, Robert L. Sutherland posted to tamoxifen review resistance moa hormone breast by misonneh on 2009-08-26 11:07:26 as along with 1 person songpku
	Mammary development meets cancer genomics [My Copy] Nat Med, Vol. 15, No. 8. (August 2009), pp. 842-844. by Aleix Prat, Charles M. Perou posted to subtypes review progression perspective moa genetics expression breast brca by misonneh on 2009-08-12 04:53:48 as along with 1 person frohike
	Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? [My Copy] Nat Rev Drug Discov, Vol. 8, No. 7. (29 July 2009), pp. 579-591. by Dunyaporn Trachootham, Jerome Alexandre, Peng Huang posted to chemotherapy moa ros by misonneh on 2009-07-22 03:32:36 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
	Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications [My Copy] Nature Reviews Genetics, Vol. 10, No. 8. (01 August 2009), pp. 578-585. by Brian D. Brown, Luigi Naldini posted to comments mirna moa review therapy by misonneh on 2009-07-20 10:10:20 as along with 5 people and 2 groups heliopais guhjy ppgardne reyez valeriehilgers microRNA Journal picks
	Mechanisms of change in gene copy number [My Copy] Nature Reviews Genetics, Vol. 10, No. 8. (01 August 2009), pp. 551-564. by P. J. Hastings, James R. Lupski, Susan M. Rosenberg, Grzegorz Ira posted to cnv moa review by misonneh on 2009-07-20 09:06:21 as along with 13 people and 1 group biovils Zephyrus sameersoi xingxu qayub nicolesoranzo pkonings jandot rdiaz fenghezi daforerog ppgardne psique Journal picks
	"Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen [My Copy] J Clin Oncol, Vol. 27, No. 21. (20 July 2009), pp. 3413-3415. by Amy M. Fowler, Richard J. Santen, D. Craig Allred posted to alternative breast esr1 moa resistance splicing tamoxifen by misonneh on 2009-07-17 05:33:49 as
	Estrogenic activity of DDT analogs and polychlorinated biphenyls. [My Copy] Journal of agricultural and food chemistry, Vol. 18, No. 6. (c 1970), pp. 1108-1112. by J. Bitman, H. C. Cecil posted to estrogen moa pcb by misonneh on 2009-06-24 03:09:58 as along with 1 person Zephyrus
	Are We Hitting the Right Combination for Hormonally Sensitive Breast Cancer? [My Copy] J Clin Oncol, Vol. 27, No. 16. (1 June 2009), pp. 2580-2582. by Debu Tripathy posted to breast comments hormone moa pharmacogenetics review tamoxifen by misonneh on 2009-05-29 06:45:04 as
	Targeting multidrug resistance in cancer [My Copy] Nature Reviews Drug Discovery, Vol. 5, No. 3., pp. 219-234. by Gergely Szakács, Jill K. Paterson, Joseph A. Ludwig, Catherine Booth-Genthe, Michael M. Gottesman posted to cancer chemotherapy moa resistance review by misonneh on 2009-04-10 09:58:34 as along with 2 people happy_manatee Petersarkies
	Replication timing and epigenetic reprogramming of gene expression: a two-way relationship? [My Copy] Nat Rev Genet, Vol. 10, No. 4. (April 2009), pp. 269-276. by Anita Gondor, Rolf Ohlsson posted to dynamic epigenetics expression moa review by misonneh on 2009-03-19 01:03:51 as along with 3 people and 1 group polivares inesdesantiago fenghezi BergmanLab
	The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor alpha for Degradation in Breast Cancer Cells [My Copy] Cancer Res, Vol. 69, No. 5. (1 March 2009), pp. 1722-1727. by Xianglin Wu, John R. Hawse, Malayannan Subramaniam, Matthew P. Goetz, James N. Ingle, Thomas C. Spelsberg posted to breast moa tamoxifen by misonneh on 2009-03-03 00:56:31 as
	A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention [My Copy] Cancer Res, Vol. 69, No. 4. (15 February 2009), pp. 1243-1254. by Craig V. Jordan posted to aromatase_inhibitor breast chemotherapy hormone moa prevention prostate review tamoxifen by misonneh on 2009-02-25 01:03:38 as
	Aberrant DNA methylation is a dominant mechanism in MDS progression to AML [My Copy] Blood (20 November 2008), blood-2008-06-163246. by Ying Jiang, Andrew Dunbar, Lukasz P. Gondek, et al.Sanjay Mohan, Manjot Rataul, Christine O'Keefe, Mikkael Sekeres, Yogen Saunthararajah, Jaroslaw P. Maciejewski posted to aml epigenetics gene_specific_methylation hematology mds moa progression by misonneh on 2009-01-19 08:47:22 as
	Gene silencing by DNA methylation in haematological malignancies [My Copy] British Journal of Haematology, Vol. 138, No. 1. (July 2007), pp. 3-11. by Boultwood, Jacqueline, Wainscoat, S. James posted to epigenetics hematology methylation moa review by misonneh on 2009-01-19 08:26:54 as
	Role of hormones in mammary cancer initiation and progression. [My Copy] Journal of mammary gland biology and neoplasia, Vol. 3, No. 1. (January 1998), pp. 49-61. by I. H. Russo, J. Russo posted to breast etiology moa proression review by misonneh on 2008-10-17 17:33:56 as
	Windows in early mammary development: critical or not? [My Copy] Reproduction, Vol. 122, No. 3. (September 2001), pp. 337-345. by C. H. Knight, A. Sorensen posted to benign breast etiology moa review by misonneh on 2008-10-17 17:33:08 as
	Human breast development. [My Copy] Journal of mammary gland biology and neoplasia, Vol. 5, No. 2. (April 2000), pp. 119-137. by B. A. Howard, B. A. Gusterson posted to breast etiology moa review by misonneh on 2008-10-17 17:32:25 as
	Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis [My Copy] Nature, Vol. 438, No. 7070. (15 December 2005), pp. 981-987. by Huijian Wu, Yupeng Chen, Jing Liang, et al.Bin Shi, Ge Wu, Ying Zhang, Dan Wang, Ruifang Li, Xia Yi, Hua Zhang, Luyang Sun, Yongfeng Shang posted to endometrix epigenetics gene_specific_methylation moa pax2 tamoxifen by misonneh on 2008-10-17 16:43:02 as along with 1 person tuck
	The natural history of ductal carcinoma in situ of the breast: a review [My Copy] Breast Cancer Research and Treatment, Vol. 97, No. 2. (May 2006), pp. 135-144. by Erbas, Bircan, Provenzano, et al. Elena, Armes, Jane, Gertig, Dorota posted to benign breast moa prognosis progression review by misonneh on 2008-10-17 16:35:32 as along with 1 person songpku
	Genetic and Epigenetic Changes in Mammary Epithelial Cells May Mimic Early Events in Carcinogenesis: Chromosomal Instability and Breast Cancer Pathogenesis (Guest Editors: Ashok R. Venkitaraman and Thea D. Tlsty) [My Copy] Journal of Mammary Gland Biology and Neoplasia, Vol. 9, No. 3., 263. by Thea D. Tlsty, Yongping G. Crawford, Charles R. Holst, et al.Colleen A. Fordyce, Jianmin Zhang, Kimberly Mcdermott, Krystyna Kozakiewicz, Mona L. Gauthier posted to benign breast epigenetics genetics invivo moa progression review by misonneh on 2008-10-17 16:34:38 as along with 2 people and 1 group simaoisc Zephyrus Breast Cancer Reading Club
	Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer [My Copy] Nature Genetics, Vol. 37, No. 4. (13 March 2005), pp. 391-400. by Mario F. Fraga, Esteban Ballestar, Ana Villar-Garea, et al.Manuel Boix-Chornet, Jesus Espada, Gunnar Schotta, Tiziana Bonaldi, Claire Haydon, Santiago Ropero, Kevin Petrie, N. Gopalakrishna Iyer, Alberto Pérez-Rosado, Enrique Calvo, Juan A. Lopez, Amparo Cano, Maria J. Calasanz, Dolors Colomer, Miguel Á. Piris, Natalie Ahn, Axel Imhof, Carlos Caldas, Thomas Jenuwein, Manel Esteller posted to epigenetics histone moa by misonneh on 2008-10-17 16:07:15 as along with 1 person hkuhn
	Cyclical DNA methylation of a transcriptionally active promoter [My Copy] Nature, Vol. 452, No. 7183. (6 March 2008), pp. 45-50. by Raphael Metivier, Rozenn Gallais, Christophe Tiffoche, et al.Christine Le Peron, Renata Z. Jurkowska, Richard P. Carmouche, David Ibberson, Peter Barath, Florence Demay, George Reid, Vladimir Benes, Albert Jeltsch, Frank Gannon, Gilles Salbert posted to dynamic methylation moa by misonneh on 2008-10-16 21:57:45 as along with 4 people vega djkt epigenetics clearbluespring
	Genome instability: a mechanistic view of its causes and consequences. [My Copy] Nature Reviews Genetics (29 January 2008) by Andrés Aguilera, Belén Gómez-González posted to instability moa review by misonneh on 2008-10-16 21:55:50 as along with 3 people catcremona inesdesantiago zwang
	Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells [My Copy] Cancer Cell International, Vol. 6 (02 May 2006), 13. by Mehdi S. Belgnaoui, Roger G. Gosden, John O. Semmes, Abdelali Haoudi posted to apoptosis cell line1 moa by misonneh on 2008-09-24 00:29:38 as
	Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. [My Copy] Nature Clinical Practice Urology, Vol. 2, No. 10. (October 2005), pp. 502-510. by E. M. Wolff, G. Liang, P. A. Jones posted to bladder epigenetics genetics moa review by misonneh on 2008-09-24 00:16:03 as
	A mathematical model of the folate cycle: new insights into folate homeostasis. [My Copy] Journal of Biological Chemistry, Vol. 279, No. 53. (31 December 2004), pp. 55008-55016. by H. F. Nijhout, M. C. Reed, P. Budu, C. M. Ulrich posted to folate moa modeling review by misonneh on 2008-09-23 21:26:14 as along with 1 person zohim1
	Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. [My Copy] Journal of Nutrition, Vol. 133, No. 11 Suppl 1. (November 2003) by S. J. James, I. P. Pogribny, M. Pogribna, B. J. Miller, S. Jernigan, S. Melnyk posted to diet folate methylation moa progression review invivo by misonneh on 2008-09-23 21:00:17 as
	The Dynamic epigenome and its implications in toxicology [My Copy] Toxicol. Sci. (3 August 2007), kfm177. by Moshe Szyf posted to epigenetics moa review toxicology by misonneh on 2008-09-23 19:37:21 as along with 2 people epigenetics guhjy
	Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. [My Copy] Current medicinal chemistry, Vol. 14, No. 28. (2007), pp. 3035-3045. by E. Badia, J. Oliva, P. Balaguer, V. Cavaillès posted to dynamic epigenetics methylation moa resistance review tamoxifen by misonneh on 2008-09-23 18:07:09 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
	DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines [My Copy] Molecular Cancer, Vol. 7 (25 January 2008), 15. by Devon J. Roll, Ashley G. Rivenbark, Wendell D. Jones, William B. Coleman posted to breast dnmt dynamic moa gene_specific_methylation by misonneh on 2008-09-23 18:06:10 as
	Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer [My Copy] British Journal of Cancer, Vol. aop, No. current. (19 February 2008) by H. Suzuki, M. Toyota, H. Caraway, et al.E. Gabrielson, T. Ohmura, T. Fujikane, N. Nishikawa, Y. Sogabe, M. Nojima, T. Sonoda, M. Mori, K. Hirata, K. Imai, Y. Shinomura, S. B. Baylin, T. Tokino posted to breast epigenetics moa wnt by misonneh on 2008-09-23 18:04:51 as
	Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells [My Copy] Oncogene, Vol. aop, No. current. by L. Fleury, M. Gerus, A. C. Lavigne, H. Richard-Foy, K. Bystricky posted to breast demethylation methylation moa by misonneh on 2008-09-23 18:03:58 as
	Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo. [My Copy] Neoplasia, Vol. 10, No. 3. (March 2008), pp. 266-278. by B. Ateeq, A. Unterberger, M. Szyf, S. A. Rabbani posted to demethylation dynamic epigenetics methylation moa by misonneh on 2008-09-23 18:02:55 as
	Epigenetic gene silencing in the Wnt pathway in breast cancer. [My Copy] Epigenetics, Vol. 3, No. 2. (r 2008), pp. 59-63. by G. J. Klarmann, A. Decker, W. L. Farrar posted to breast epigenetics moa review wnt gene_specific_methylation by misonneh on 2008-09-23 17:57:02 as
	Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation [My Copy] Nature Genetics, Vol. 40, No. 6. (18 May 2008), pp. 741-750. by Yutaka Kondo, Lanlan Shen, Alfred S. Cheng, et al.Saira Ahmed, Yanis Boumber, Chantale Charo, Tadanori Yamochi, Takeshi Urano, Koichi Furukawa, Bernard Kwabi-Addo, David L. Gold, Yoshitaka Sekido, Tim H. Huang, Jean-Pierre J. Issa posted to epigenetics methylation moa by misonneh on 2008-09-23 17:55:02 as along with 4 people suizifish oelemento djkt inesdesantiago
	Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. [My Copy] Gene, Vol. 210 (1998), pp. 1-7. by M. S. Jhaveri, C. S. Morrow posted to methylation moa by misonneh on 2008-09-11 19:32:13 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/moa

review	305
breast	260
genetics	162
epigenetics	161
methylation	153
pharmacogenetics	126
statistics	87
gene_specific_methylation	66
comments	65
gwas	63
biomarker	62
prognosis	60
association	53
tamoxifen	53
chemotherapy	47
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
guideline	35
resistance	35
survival	35
meta_analysis	34
global	33
prediction	33
response	32
epidemiology	31
epistasis	30
adr	29
dynamic	28
korean	28
technology	27
diagnosis	26
haplotype	26
prostate	26
time_to_event	25
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
database	19
prevention	19
progression	18
lung	17
perspective	17
risk_factor	17
line1	16
pooling	16
therapy	16
immunity	14
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
phenotype	13
tool	13
5mdc	12
age	12
randomized_controlled_trial	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
hormone	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
her2	7
hla	7
kim_	7
mdr1	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
epilepsy	6
histone	6
hyper_hypo	6
maternal	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
methodology	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
public	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
bayesian	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
egfr_pathway	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovarian	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
risk_assessment	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
anthracycline	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
ki67	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's moa [47 articles] Export

misonneh's tags